These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20107930)

  • 1. Infliximab-related hepatitis: discussion of a case and review of the literature.
    Mancini S; Amorotti E; Vecchio S; Ponz de Leon M; Roncucci L
    Intern Emerg Med; 2010 Jun; 5(3):193-200. PubMed ID: 20107930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis.
    Marques M; Magro F; Cardoso H; Carneiro F; Portugal R; Lopes J; Costa Santos C
    Inflamm Bowel Dis; 2008 May; 14(5):723-5. PubMed ID: 17929297
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatotoxicity of anti-TNF agents.
    Bonacini M; Ghabril M; Bonkovsky HL
    Dig Dis Sci; 2014 May; 59(5):1070-1. PubMed ID: 24652111
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab.
    Haennig A; Bonnet D; Thebault S; Alric L
    Gastroenterol Clin Biol; 2010 Sep; 34(8-9):e7-8. PubMed ID: 20189334
    [No Abstract]   [Full Text] [Related]  

  • 5. Atypical Mycobacterium marinum infection (Aquarium granuloma) in a patient on TNFα antagonist therapy for psoriatic arthritis.
    Ribot E; Poisnel E; De Biasi C; Roudier J; Balandraud N
    Joint Bone Spine; 2014 May; 81(3):272-3. PubMed ID: 24387972
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of drug-induced liver injury from tumor necrosis factor antagonists.
    Björnsson ES; Gunnarsson BI; Gröndal G; Jonasson JG; Einarsdottir R; Ludviksson BR; Gudbjörnsson B; Olafsson S
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):602-8. PubMed ID: 25131534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune hepatitis during infliximab therapy for Crohn's disease: a case report.
    Doyle A; Forbes G; Kontorinis N
    J Crohns Colitis; 2011 Jun; 5(3):253-5. PubMed ID: 21575891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Onset Autoimmune Hepatitis during Anti-Tumor Necrosis Factor-Alpha Treatment in Children.
    Ricciuto A; Kamath BM; Walters TD; Frost K; Carman N; Church PC; Ling SC; Griffiths AM
    J Pediatr; 2018 Mar; 194():128-135.e1. PubMed ID: 29274889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.
    Rossi RE; Parisi I; Despott EJ; Burroughs AK; O'Beirne J; Conte D; Hamilton MI; Murray CD
    World J Gastroenterol; 2014 Dec; 20(46):17352-9. PubMed ID: 25516646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal epidural abscess associated with infliximab treatment for psoriatic arthritis. Case report.
    Smith AP; Musacchio MJ; O'Toole JE
    J Neurosurg Spine; 2008 Sep; 9(3):261-4. PubMed ID: 18928222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.
    Ramos-Casals M; Brito-Zerón P; Muñoz S; Soria N; Galiana D; Bertolaccini L; Cuadrado MJ; Khamashta MA
    Medicine (Baltimore); 2007 Jul; 86(4):242-251. PubMed ID: 17632266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept tolerance in a patient with previous infliximab-induced hepatitis.
    Becker H; Willeke P; Domschke W; Gaubitz M
    Clin Rheumatol; 2008 Dec; 27(12):1597-8. PubMed ID: 18795397
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept.
    Carlsen KM; Riis L; Madsen OR
    Clin Rheumatol; 2009 Aug; 28(8):1001-3. PubMed ID: 19370307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment with etanercept of a patient with psoriatic arthritis after adalimumab-related hepatotoxicity.
    Massarotti M; Marasini B
    Int J Immunopathol Pharmacol; 2009; 22(2):547-9. PubMed ID: 19505409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis.
    Ozorio G; McGarity B; Bak H; Jordan AS; Lau H; Marshall C
    Med J Aust; 2007 Nov; 187(9):524-6. PubMed ID: 17979620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of recurrent cutaneous abscesses during therapy with infliximab.
    De Simone C; Murri R; Maiorino A; Venier A; Caldarola G
    Clin Ther; 2011 Dec; 33(12):1993-6. PubMed ID: 22088412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab.
    Cravo M; Silva R; Serrano M
    BioDrugs; 2010 Dec; 24 Suppl 1():25-7. PubMed ID: 21175232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of hepatitis B in a patient with Crohn's disease treated using infliximab.
    Ojiro K; Naganuma M; Ebinuma H; Kunimoto H; Tada S; Ogata H; Iwao Y; Saito H; Hibi T
    J Gastroenterol; 2008; 43(5):397-401. PubMed ID: 18592158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review on golimumab in the treatment of psoriatic arthritis.
    Urdaneta M; Jethwa H; Sultan R; Abraham S
    Immunotherapy; 2017 Sep; 9(11):871-889. PubMed ID: 28838285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis.
    Fénix-Caballero S; Alegre-del Rey EJ; Castaño-Lara R; Puigventós-Latorre F; Borrero-Rubio JM; López-Vallejo JF
    J Clin Pharm Ther; 2013 Aug; 38(4):286-93. PubMed ID: 23590560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.